Twelve mutants of Streptomyces galilaeus (ATCC 31615) blocked in the production of aclacinomycin A, an anthracycline antibiotic with significant antitumour activity, accumulated intermediates of the biosynthesis of aclacinomycins and several anthracyclines with variant sugar moieties. Three of these aklavinone glycosides have not been described before. Mutant strains H028, H061 and H036 were blocked before the formation of aklavinone, a common intermediate for most anthracyclines. Strain H039 accumulated aklavinone and H026, H035, H038 and H054 had mutations that changed glycosylation of aklavinone. Characterization of the mutants and their products is described.
EckardtK., TresseltD., SchumannG., IhnW., WagnerC.1985a; Isolation and chemical structure of aklanonic acid, a potential early intermediate in the biosynthesis of anthracyclines. J Antibiot 38:1034–1039
EckardtK., SchumannG., GrafeU., IhnW., WagnerC., FleckW., ThrumH.1985b; Preparation of labelled aklanonic acid and its bioconversion to anthracyclinones by mutants of Streptomyces griseus. J Antibiot 38:1096–1097
EckardtK., SchumannG., TresseltD., IhnW.1988; Biosynthesis of anthracyclinones: isolation of a new early cyclization product aklaviketone. J Antibiot 41:788–793
EppJ., HuberM., TurnerJ., GoodsonT., SchonerB.1989; Production of hybrid macrolide antibiotic in Streptomyces ambofaciens and Streptomyces lividans by introduction of a cloned carbomycin biosynthetic gene from Streptomyces thermotolerans. Gene 85:293–301
HopwoodD. A., MalpartidaF., KieserH., IkedaH., DuncanJ., FujiiI., RuddB., FlossH., OmuraS.1985; Production of ‘hybrid’ antibiotics by genetic engineering. Nature 314:642–644
HoshinoT., SekineY., FujiwaraA.1983; Microbial conversion of anthracycline antibiotics. I. Microbial conversion of aclacinomycin B to aclacinomycin A. J Antibiot 36:1458–1462
MatsuzawaY., YoshimotoA., ShibamotoN., TobeH., OkiT., NaganawaH., TakeuchiT., UmezawaH.1981; New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1 II. Structure of 2-hydroxyaklavinone and new aklavinone glycosides. J Antibiot 34:959–964
OkiT., YoshimotoA., MatsuzawaY., TakeuchiT., UmezawaH.1980; Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone. J Antibiot 33:1331–1341
StrohlW., BartelP., ConnorsN., ZhuC.-B., DoschD., BealeJ., FlossH., Stuzman-EngwallK., OttenS., HutchinsonC. R.1989; Biosynthesis of natural and hybrid polyketides by anthracycline-producing Streptomycetes. In Genetics and Molecular JSiology of Industrial Microorganisms pp. 68–84 Edited by HershbergerC., QueenerS., HegemanG. . Washington, DC: American Society for Microbiology;
WagnerC., EckardtK., SchumannG., IhnW., TresseltD.1984; Microbial transformation of aklanonic acid, a potential early intermediate in the biosynthesis of anthracyclines. J Antibiot 37:691–692
YoshimotoA., OgasawaraT., KitamuraI., OkiT., InuiT., TakeuchiT., UmezawaH.1979; Enzymatic conversion of aclacinomycin A to Y by a specific oxidoreductase in Streptomyces. J Antibiot 32:472–481
YoshimotoA., MatsuzawaY., OkiT., TakeuchiT., UmezawaH.1981; New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1 I. Isolation and characterization of various blocked mutants. J Antibiot 34:951–958